Monogenic Diabetes Group, Genetic Endocrinology Unit and Laboratory of Molecular & Cellular Endocrinology/LIM25, School of Medicine, University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Diabetes Unit, Clinics Hospital, School of Medicine, University of Sao Paulo (USP), Sao Paulo, SP, Brazil.
Mol Genet Genomic Med. 2019 Dec;7(12):e962. doi: 10.1002/mgg3.962. Epub 2019 Oct 8.
Maturity-onset diabetes of the young (MODY) is a form of monogenic diabetes with autosomal dominant inheritance. To date, mutations in 11 genes have been frequently associated with this phenotype. In Brazil, few cohorts have been screened for MODY, all using a candidate gene approach, with a high prevalence of undiagnosed cases (MODY-X).
We conducted a next-generation sequencing target panel (tNGS) study to investigate, for the first time, a Brazilian cohort of MODY patients with a negative prior genetic analysis. One hundred and two patients were selected, of which 26 had an initial clinical suspicion of MODY-GCK and 76 were non-GCK MODY.
After excluding all benign and likely benign variants and variants of uncertain significance, we were able to assign a genetic cause for 12.7% (13/102) of the probands. Three rare MODY subtypes were identified (PDX1/NEUROD1/ABCC8), and eight variants had not been previously described/mapped in genomic databases. Important clinical findings were evidenced in some cases after genetic diagnosis, such as MODY-PDX1/HNF1B.
A multiloci genetic approach allowed the identification of rare MODY subtypes, reducing the large percentage of MODY-X in Brazilian cases and contributing to a better clinical, therapeutic, and prognostic characterization of these rare phenotypes.
青年起病的成年型糖尿病(MODY)是一种常染色体显性遗传的单基因糖尿病。迄今为止,已有 11 种基因突变与该表型频繁相关。在巴西,很少有队列进行 MODY 筛查,均采用候选基因方法,漏诊率较高(MODY-X)。
我们进行了下一代测序靶向panel(tNGS)研究,首次调查了具有阴性遗传分析的巴西 MODY 患者队列。共选择了 102 名患者,其中 26 名患者最初临床怀疑为 MODY-GCK,76 名患者为非 GCK MODY。
排除所有良性和可能良性变异以及意义不明的变异后,我们能够为 102 名先证者中的 12.7%(13/102)确定遗传病因。确定了三种罕见的 MODY 亚型(PDX1/NEUROD1/ABCC8),并且有 8 种变异之前未在基因组数据库中描述/定位。在一些病例中,遗传诊断后发现了重要的临床发现,如 MODY-PDX1/HNF1B。
多基因遗传方法可识别罕见的 MODY 亚型,降低了巴西病例中 MODY-X 的高比例,并有助于更好地对这些罕见表型进行临床、治疗和预后特征描述。